Discovery of AZD9750, an Orally Bioavailable Androgen Receptor Degrader for the Treatment of Prostate Cancer
Year: 2026
Type: article
Source: Journal of Medicinal Chemistry
Authors: James S. Scott, Laura Evans, Peter C. Astles, Argyrides Argyrou, Sharan K. Bagal, David Beattie, Erin L. Braybrooke, Doyle J. Cassar, Claire Crafter, Coura Diène, Gary Fairley, Charlene Fallan, Graham Fraser, Nuria Galeano-Dalmau, Thomas G. Hammond, Andreas K. Hock, Thomas Jones, Jasper Komen, Gillian M. Lamont, Chrysiis Michaloglou, Michael J. Niedbala, Antonio Ramos-Montoya, Monica C. Rodrigo-Brenni, Martin J. Packer, Stuart Pearson, Andy Pike, Markus Schade, Joseph Shaw, Ziyanda Shologu, Oliver Steward
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Funder: AstraZeneca
OpenAlex ID: W7126262948